 PASADENA, Calif.-- BUSINESS WIRE --Arrowhead Pharmaceuticals Inc. NASDAQ: ARWR today announced that it is scheduled to present on January 9, 2023, at 11:15 a.m. ET at the 41st Annual J.P. Morgan Healthcare Conference being held in San Francisco. 